Early Detection Research Network

Biomarkers: the key to early detection

Navigation

Personal tools

You are here: Home / Protocols / Biomarker Dev Lab At Moffitt Supplement

Abbreviated Name: Biomarker Dev Lab At Moffitt Supplement

Protocol ID: 72

Lead Investigator: Tockman, Melvyn S. — H. Lee Moffitt Cancer Center

Coordinating Investigator:

No coordinating investigator defined.

Involved Investigator Sites:

No involved investigator sites defined.

Biomarker Name:

Design:

Field(s) of Research: UNKNOWN

Collaborative Group Text: Lung and Upper Aerodigestive Cancers Research Group

Phased Status:

Abstract:

Aims:

Analytic Method:

Comments:

Biomarkers:

There are currently no biomarkers annotated for this protocol.

Datasets:

No datasets are currently associated with this protocol.

: Announcement 04/26/2017

A new funding opportunity associated with the Beau Biden Cancer Moonshot Initiative, Integration and Validation of Emerging Technologies to Accelerate Cancer Research, has been released and is due May 10, 2017. Click here for more information.; Announcement 03/14/2017

Thank you to everyone who made the March 2017 EDRN Steering Committee Meeting a success. The next EDRN Steering Committee Meeting will be on September 12-14, 2017, in Seattle, WA.

EDRN Founder Honored: Dr. Sudhir Srivastava was honored with the Distinguished Service Award from the American Pancreatic Association at the group's annual meeting this year, for his outstanding commitment to pancreatology.